National Music Centre Appoints Steve Kane as Board Chair Announces Governance Updates GigaIPOs Reflect Structural Challenges in Public Markets Analysis Suggests ADP Private Payrolls Surge Past Expectations in April Signaling Stable Labor Market AnheuserBusch InBev Shares Edge Lower After Sales Miss Estimates The Mandalorian and Grogu Opens to 82 Million Marking Disneys Lowest Star Wars Debut US Advances AI Integration in Asia Following TrumpXi Meeting Senior Official Says XOMAP Q1 2026 Earnings Preferred Stock Reports EPS Miss Amid Royalty Revenue Uncertainty Kinsale Capital Group KNSL Q1 2026 Earnings Underwriting Strength Drives Another EPS Beat PFSI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Stepan Company SCL Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises STNE Q1 2026 Earnings EPS Misses Estimates by 391 Stock Edges Higher BrightView Holdings Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Earnings Shortfall Verizon VZ Holds Steady at 4834 as Consolidation Continues Electronic Arts EA Holds Steady Near Midpoint as Investors Eye Key Levels Eaton Vance TaxAdvantage Global Dividend Opp ETO Rises 1 Approaching Key Resistance Zone Haverty Furniture HVT Sees Slight Decline Holds Near Support Levels Franklin Universal Trust FT Edges Higher Amid Modest Trading Activity Amazon Quanta Services and Monster Beverage Approach Potential Buy Zones as Market Momentum Shifts NEUP Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency Scinai Immunotherapeutics SCNI Extends Losses as Stock Hovers Near Key Support CrossAmerica Partners CAPL Holds Steady With Modest Gain as Consolidation Continues Kestra Medical Technologies KMTS Holds Steady Near Support Testing Resistance Levels Star Equity Holdings STRR Edges Higher Key Levels and Momentum in Focus Cambium Networks CMBM Hovers Near Support as Trading Volume Remains Subdued Woodside Energy WDS Holds Steady Near 2175 Amid Mixed Energy Sector Sentiment Nutex Health NUTX Surges 36 Key Levels and Technical Outlook Bolt Biotherapeutics BOLT Slips 12 as Shares Test Key Support at 465